FT/IR-6100 Fourier Transform Infrared Spectrometer. MALDI-
TOF-mass spectra were measured on a PerSeptive Biosystems,
Voyager RP-DE/H mass spectrometer equipped with a nitrogen
laser (l = 337 nm).
the mixture was filtered and concentrated in vacuo. The residue
was directly purified by column chromatography on silica gel
(gradually from 50 to 83% of ethyl acetate in toluene) to give the
1
sialoside 5 as an a-isomer based on H NMR analysis (138 mg,
95%) as a white solid: [a]D20 +29.0 (c 0.1, CHCl3); mp 100–101 ◦C;
IR (neat, cm-1) 3388, 2955, 1747, 1518, 1452; MALDI-TOF-MS
m/z calcd for C47H55Cl3N2O21 (M+Na)+ 1111.2, found 1111.2; 1H
NMR (500 MHz, CDCl3) d 7.76 (d, J = 7.4 Hz, 2H, Fmoc), 7.60
(dd, J = 7.9, 9.4 Hz, 2H, Fmoc), 7.40 (t, J = 7.5 Hz, 2H, Fmoc),
7.32 (tdd, J = 7.3, 2.9, 1.2 Hz, 2H, Fmoc), 5.88 (ddd, J = 23.2, 10.3,
5.3 Hz, 1H, OCH2CH CH2), 5.37 (ddd, J = 11.2, 5.6, 2.6 Hz, 1H,
H-8), 5.37 (d, J = 9.7 Hz, 1H, TrocNH), 5.30 (dd, J = 10.0, 1.8 Hz,
1H, H-7), 5.30 (dd, J = 10.0, 1.8 Hz, 1H, AcHN), 5.29 (dq, J =
15.6, 1.5 Hz, 1H, OCH2CH CH2), 5.22 (dq, J = 10.3, 1.2 Hz, 1H,
OCH2CH CH2), 5.07 (dd, J = 10.5, 9.7 Hz, 1H, H-3¢), 5.03 (td,
J = 10.5, 4.7 Hz, 1H, H-4), 4.94 (d, J = 3.8 Hz, 1H, H-1¢), 4.61 (d,
J = 12.0 Hz, 1H, Cl3CCH2), 4.54 (d, J = 12.0 Hz, 1H, Cl3CCH2),
4.42 (dd, J = 10.3, 7.6 Hz, 1H, Fmoc), 4.33 (dd, J = 10.6, 7.6 Hz,
1H, Fmoc), 4.32 (dd, J = 12.0, 3.2 Hz, 1H, H-9a), 4.23 (dd, J =
15.0, 5.9 Hz, 1H, Fmoc), 4.23 (dd, J = 7.9, 2.1 Hz, 1H, H-6a¢),
4.18 (ddt, J = 12.6, 5.3, 1.5 Hz, 1H, OCH2CH CH2), 4.15 (dd,
J = 10.9, 1.8 Hz, 1H, H-6), 4.09 (dd, J = 12.0, 5.6 Hz, 1H, H-9b),
4.07 (dd, J = 10.3, 3.8 Hz, 1H, H-2¢), 4.05 (q, J = 10.6 Hz, 1H,
H-5), 4.00 (ddt, J = 12.9, 6.5, 1.2 Hz, 1H, OCH2CH CH2), 3.97
(dd, J = 10.0, 5.0 Hz, 1H, H-4¢), 3.81 (s, 3H, CO2Me), 3.77 (dd,
J = 10.9, 2.9 Hz, 1H, H-6b¢), 3.77 (ddd, J = 10.9, 4.4, 1.8 Hz, 1H,
H-5¢), 3.48 (d, J = 5.0 Hz, 1H, HO-4¢), 2.66 (dd, J = 13.5, 5.0 Hz,
1H, H-3eq), 2.13 (s, 3H, Ac), 2.11 (s, 3H, Ac), 2.07 (s, 3H, Ac),
2.06 (dd, J = 12.6, 10.0 Hz, 1H, H-3ax), 2.03 (s, 3H, Ac), 1.90 (s,
3H, Ac); 13C NMR (125 MHz, CDCl3) d 170.96, 170.63, 170.27,
170.11, 169.75, 168.21, 155.65, 154.23, 143.26, 143.18, 141.25,
133.16, 127.91, 127.21, 125.20, 120.04, 118.32, 97.92, 96.60, 95.31,
77.36, 74.57, 72.28, 71.09, 70.39, 68.78, 68.65, 68.57, 67.79, 67.30,
62.81, 62.3, 54.23, 52.88, 49.84, 46.62, 37.79, 30.86, 23.15, 21.05,
20.85, 20.69, 20.55; a-Confuguration of the sialoside linkage23 was
determined based on the 3JC1-3Hax of 13.9 Hz.
Allyl 2,3-Di-O-benzoyl-6-O-(Methyl 5-acetamide-4,7,8,9-
tetra-O-acetyl-3,5-dideoxy-D-glycero-a-D-galacto-2-
nonulopyranosylonate)-a-D-galactopyranoside 3
To a solution of the NAc donor 1 (30.0 mg, 45.3 mmol), the
acceptor 2 (29.1 mg, 68.0 mmol), and dry MS4A in EtCN (1.0 mL)
was added TMSOTf (8.2 mL, 45.3 mmol) at -78 ◦C, and the
resulting mixture was stirred at this temperature for 6 h. After
the reaction was quenched by adding the excess triethylamine
at -78 ◦C, the mixture was filtered and concentrated in vacuo.
The residue was directly purified by column chromatography on
silica gel from 67% to 100% of ethyl acetate in toluene) to give
the disaccharide 3 (35.1 mg and 86% (sum of a + b), a : b =
93 : 7). These a- and b-isomers were further separated by column
chromatography on silica gel (gradually from 67% to 100% of
ethyl acetate in toluene). Data for a-isomer (white solid): [a]D20
◦
+69.0 (c 0.1, CHCl3); mp 94–96 C; IR (neat, cm-1) 3377, 2957,
1742, 1538, 1452; MALDI-TOF-MS m/z calcd for C43H51NO20
(M+Na)+ 924.3, found 924.3; 1H NMR (500 MHz, CDCl3) d 8.01
(ddd, J = 16.3, 8.4, 1.3 Hz, 4H, Bz), 7.52–7.48 (m, 2H, Bz), 7.37
(td, J = 7.4, 3.6 Hz, 4H, Bz), 5.85 (ddd, J = 22.2, 10.5, 5.9 Hz, 1H,
OCH2CH CH2), 5.69 (dd, J = 2.1, 0.9 Hz, 1H, H-2¢), 5.69 (dd,
J = 2.1, 0.9 Hz, 1H, H-3¢), 5.37 (ddd, J = 13.7, 7.4, 2.7 Hz, 1H,
H-8), 5.34 (dd, J = 7.4, 2.0 Hz, 1H, H-7), 5.32 (d, J = 2.0 Hz, 1H,
H-1¢), 5.30 (ddd, J = 15.5, 3.2, 1.6 Hz, 1H, OCH2CH CH2), 5.21
(d, J = 9.7 Hz, 1H, AcHN), 5.14 (ddd, J = 10.6, 2.7, 1.1 Hz, 1H,
OCH2CH CH2), 4.90 (ddd, J = 12.0, 10.0, 4.7 Hz, 1H, H-4), 4.39
(bd, J = 2.9 Hz, 1H, H-4¢), 4.39 (dd, J = 12.3, 2.7 Hz, 1H, H-9a),
4.26 (ddt, J = 13.2, 4.6, 1.6 Hz, 1H, OCH2CH CH2), 4.17 (t, J =
6.2 Hz, 1H, H-5¢), 4.12 (dd, J = 10.7, 2.1 Hz, 1H, H-6), 4.06 (dd,
J = 12.3, 6.2 Hz, 1H, H-9b), 4.06 (q, J = 9.7 Hz, 1H, H-5), 4.05
(ddt, J = 13.2, 7.3, 1.6 Hz, 1H, OCH2CH CH2), 3.93 (dd, J =
9.7, 5.6 Hz, 1H, H-6a¢), 3.82 (s, 3H, CO2Me), 3.82 (dd, J = 9.7,
7.3 Hz, 1H, H-6b¢), 3.05 (d, J = 4.6 Hz, 1H, HO-4¢), 2.60 (dd, J =
12.7, 4.7 Hz, 1H, H-3eq), 2.14 (s, 3H, Ac), 2.11 (s, 3H, Ac), 2.03
(s, 3H, Ac), 2.01 (dd, J = 12.6, 7.2 Hz, 1H, H-3ax), 1.94 (s, 3H,
Ac), 1.88 (s, 3H, Ac); 13C NMR (125 MHz, CDCl3) d 170.91,
170.87, 170.21, 170.17, 168.08, 165.99, 165.91, 133.62, 133.13,
133.1, 129.81, 129.78, 129.72, 129.58, 128.33, 117.37, 98.73, 95.79,
72.90, 71.15, 69.25, 69, 68.92, 68.55, 68.26, 67.73, 67.48, 62.98,
62.60, 53.01, 49.43, 37.05, 23.15, 21.03, 20.8, 20.76, 20.58; a-
Confuguration of the sialoside linkage23 was determined based
on the 3JC1-3Hax of 6.9 Hz.
Allyl 2-O-Benzoyl-6-O-benzyl-3-O-(methyl 5-acetamide-
4,7,8,9-tetra-O-acetyl-3,5-dideoxy-D-glycero-a-D-
galacto-2-nonulopyranosylonate)-a-D-galactopyranoside 7
To a solution of the donor 1 (30.0 mg, 45.3 mmol) and the acceptor
6 (28.2 mg, 68.0 mmol), and dry MS4A in◦EtCN (1.0 mL) was
added TMSOTf (4.1 ml, 22.7 mmol) at -78 C, and the resulting
mixture was stirred at this temperature for 6 h. After the reaction
was quenched by adding the excess triethylamine at -78 ◦C,
the mixture was filtered and concentrated in vacuo. The residue
was directly purified by column chromatography on silica gel
(gradually from 67% to 100% of ethyl acetate in toluene) to give
1
the disaccharide 7 essentially as an a-isomer based on H NMR
Allyl 2-Amino-2-deoxy-3-O-9-fluorenylmethoxycarbonyl-2-N-
2,2,2-trichloroethoxycarbonyl-6-O-(methyl 5-acetamide-
4,7,8,9-tetra-O-acetyl-3,5-dideoxy-D-glycero-a-D-galacto-2-
nonulopyranosylonate)-a-D-glucopyranoside 5
analysis (32.3 mg, 80%) as a white solid: [a]2D0 +31.0 (c 0.1, CHCl3);
◦
mp 77–78 C; IR (neat, cm-1) 3375, 2928, 1748, 1537, 1453;
MALDI-TOF-MS m/z calcd for C43H53NO19 (M+Na)+ 910.3,
1
found 910.2; H NMR (500 MHz, CDCl3) d 8.09 (dd, J = 8.4,
To a solution of the donor 1 (88.0 mg, 133 mmol), the acceptor
4 (128 mg, 207 mmol), and dry MS4A in EtCN (1.0 mL) was
added TMSOTf (5.4 mL, 29.8 mmol) at -78 ◦C, and the resulting
mixture was stirred at this temperature for 6 h. After the reaction
was quenched by adding the excess triethylamine at -78 ◦C,
1.4 Hz, 2H, Bz), 7.57 (tt, J = 7.4, 1.5 Hz, 1H, Bz), 7.45 (t, J =
7.8 Hz, 2H, Bz), 7.36–7.32 (m, 4H, Bn), 7.27 (tt, J = 6.6, 2.3 Hz,
1H, Bn), 5.88 (ddd, J = 22.2, 10.5, 6.0 Hz, 1H, OCH2CH CH2),
5.40 (dd, J = 10.3, 3.7 Hz, 1H, H-2¢), 5.32 (dd, J = 5.6, 2.4 Hz,
1H, H-8), 5.31 (dd, J = 5.0, 2.4 Hz, 1H, H-7), 5.29 (dq, J = 17.2,
7246 | Org. Biomol. Chem., 2011, 9, 7243–7248
This journal is
The Royal Society of Chemistry 2011
©